In patients with an a priori clinical diagnosis of glomerulopathy, pathogenic variants in COL4A5 or COL4A3 were detected in eight individuals, confirming the diagnosis of Alport syndrome. This evidence concerns the gene COL4A3 and lipoprotein glomerulopathy.